EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access

Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes

Writing Group for the CKD Prognosis Consortium, Morgan E Grams, Josef Coresh, Kunihiro Matsushita, Shoshana H Ballew, Yingying Sang, Aditya Surapaneni, Natalia Alencar de Pinho, Amanda Anderson, Lawrence J Appel, Johan Ärnlöv, Fereidoun Azizi und 48 weitere

JAMA · 03.10.2023 · 330 (13) · 1266

DOI: 10.1001/jama.2023.17002 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift JAMA, erschienen am 03.10.2023. Verfasst von Writing Group for the CKD Prognosis Consortium und 59 weiteren Autor:innen. Beteiligte Einrichtung: Division of Precision Medicine, Department of Medicine, Grossman School of Medicine, New York University, New York, New York. Hauptthemen laut MEDLINE: Albuminuria, Creatinine, Cystatin C, Glomerular Filtration Rate. Die Arbeit wurde bisher 422-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council, NIDDK NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Chronic kidney disease (low estimated glomerular filtration rate [eGFR] or albuminuria) affects approximately 14% of adults in the US.

Objective

To evaluate associations of lower eGFR based on creatinine alone, lower eGFR based on creatinine combined with cystatin C, and more severe albuminuria with adverse kidney outcomes, cardiovascular outcomes, and other health outcomes. Design, Setting, and Participants Individual-participant data meta-analysis of 27 503 140 individuals from 114 global cohorts (eGFR based on creatinine alone) and 720 736 individuals from 20 cohorts (eGFR based on creatinine and cystatin C) and 9 067 753 individuals from 114 cohorts (albuminuria) from 1980 to 2021. Exposures The Chronic Kidney Disease Epidemiology Collaboration 2021 equations for eGFR based on creatinine alone and eGFR based on creatinine and cystatin C; and albuminuria estimated as urine albumin to creatinine ratio (UACR). Main Outcomes and Measures The risk of kidney failure requiring replacement therapy, all-cause mortality, cardiovascular mortality, acute kidney injury, any hospitalization, coronary heart disease, stroke, heart failure, atrial fibrillation, and peripheral artery disease. The analyses were performed within each cohort and summarized with random-effects meta-analyses.

Results

Within the population using eGFR based on creatinine alone (mean age, 54 years [SD, 17 years]; 51% were women; mean follow-up time, 4.8 years [SD, 3.3 years]), the mean eGFR was 90 mL/min/1.73 m 2 (SD, 22 mL/min/1.73 m 2 ) and the median UACR was 11 mg/g (IQR, 8-16 mg/g). Within the population using eGFR based on creatinine and cystatin C (mean age, 59 years [SD, 12 years]; 53% were women; mean follow-up time, 10.8 years [SD, 4.1 years]), the mean eGFR was 88 mL/min/1.73 m 2 (SD, 22 mL/min/1.73 m 2 ) and the median UACR was 9 mg/g (IQR, 6-18 mg/g). Lower eGFR (whether based on creatinine alone or based on creatinine and cystatin C) and higher UACR were each significantly associated with higher risk for each of the 10 adverse outcomes, including those in the mildest categories of chronic kidney disease. For example, among people with a UACR less than 10 mg/g, an eGFR of 45 to 59 mL/min/1.73 m 2 based on creatinine alone was associated with significantly higher hospitalization rates compared with an eGFR of 90 to 104 mL/min/1.73 m 2 (adjusted hazard ratio, 1.3 [95% CI, 1.2-1.3]; 161 vs 79 events per 1000 person-years; excess absolute risk, 22 events per 1000 person-years [95% CI, 19-25 events per 1000 person-years]). Conclusions and Relevance In this retrospective analysis of 114 cohorts, lower eGFR based on creatinine alone, lower eGFR based on creatinine and cystatin C, and more severe UACR were each associated with increased rates of 10 adverse outcomes, including adverse kidney outcomes, cardiovascular diseases, and hospitalizations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlbuminuriaCreatinineCystatin CGlomerular Filtration RateRenal Insufficiency, ChronicAlbuminsAdultFemaleHumansMaleMiddle AgedAtrial FibrillationRetrospective StudiesAgedDisease ProgressionInternationalityComorbidity

Substanzen

CreatinineCystatin CAlbumins

Autor:innen und Institutionen

  • Division of Precision Medicine, Department of Medicine, Grossman School of Medicine, New York University, New York, New York.
  • Department of Epidemiology and Welch Center for Prevention, Epidemiology, and Clinical Research, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
  • Centre for Research in Epidemiology and Population Health, Paris-Saclay University, Inserm U1018, Versailles Saint-Quentin University, Clinical Epidemiology Team, Villejuif, France.
  • School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana.
  • School of Health and Social Studies, Dalarna University, Falun, Sweden.
  • Department of Neurobiology, Care Sciences, and Society, Family Medicine and Primary Care Unit, Karolinska Institutet, Huddinge, Sweden.

Förderung

  • Medical Research Council
  • NIDDK NIH HHS
  • NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Writing Group for the CKD Prognosis Consortium, Grams, M. E., Coresh, J., Matsushita, K., Ballew, S. H., Sang, Y., Surapaneni, A., Alencar de Pinho, N., Anderson, A., Appel, L. J., Ärnlöv, J., Azizi, F., Bansal, N., Bell, S., Bilo, H. J. G., Brunskill, N. J., Carrero, J. J., Chadban, S., Chalmers, J., …, & Schaeffner, E. (2023). Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes. JAMA, 330(13), 1266. https://doi.org/10.1001/jama.2023.17002

Vancouver

Writing Group for the CKD Prognosis Consortium, Grams ME, Coresh J, Matsushita K, Ballew SH, Sang Y, et al. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes. JAMA. 2023;330(13):1266. doi:10.1001/jama.2023.17002

BibTeX
@article{WritingGroupfortheCKDPrognosisConsortium2023,
  author = {Writing Group for the CKD Prognosis Consortium, Writing Group for the CKD Prognosis Consortium and Grams, Morgan E and Coresh, Josef and Matsushita, Kunihiro and Ballew, Shoshana H and Sang, Yingying and Surapaneni, Aditya and Alencar de Pinho, Natalia and Anderson, Amanda and Appel, Lawrence J and Ärnlöv, Johan and Azizi, Fereidoun and Bansal, Nisha and Bell, Samira and Bilo, Henk J G and Brunskill, Nigel J and Carrero, Juan J and Chadban, Steve and Chalmers, John and Chen, Jing and Ciemins, Elizabeth and Cirillo, Massimo and Ebert, Natalie and Evans, Marie and Ferreiro, Alejandro and Fu, Edouard L and Fukagawa, Masafumi and Green, Jamie A and Gutierrez, Orlando M and Herrington, William G and Hwang, Shih-Jen and Inker, Lesley A and Iseki, Kunitoshi and Jafar, Tazeen and Jassal, Simerjot K and Jha, Vivekanand and Kadota, Aya and Katz, Ronit and Köttgen, Anna and Konta, Tsuneo and Kronenberg, Florian and Lee, Brian J and Lees, Jennifer and Levin, Adeera and Looker, Helen C and Major, Rupert and Melzer Cohen, Cheli and Mieno, Makiko and Miyazaki, Mariko and Moranne, Olivier and Muraki, Isao and Naimark, David and Nitsch, Dorothea and Oh, Wonsuk and Pena, Michelle and Purnell, Tanjala S and Sabanayagam, Charumathi and Satoh, Michihiro and Sawhney, Simon and Schaeffner, Elke},
  title = {Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes},
  journal = {JAMA},
  year = {2023},
  volume = {330},
  number = {13},
  pages = {1266},
  doi = {10.1001/jama.2023.17002}
}
Kostenlos starten →